<VariationArchive VariationID="1071658" VariationName="NM_018006.5(TRMU):c.803del (p.Ala268fs)" VariationType="Deletion" Accession="VCV001071658" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-17" DateCreated="2021-05-10" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1065053" VariationID="1071658">
      <GeneList>
        <Gene Symbol="TRMU" FullName="tRNA mitochondrial 2-thiouridylase" GeneID="55687" HGNC_ID="HGNC:25481" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="46335714" stop="46357340" display_start="46335714" display_stop="46357340" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="46731297" stop="46753236" display_start="46731297" display_stop="46753236" Strand="+" />
          </Location>
          <OMIM>610230</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018006.5(TRMU):c.803del (p.Ala268fs)</Name>
      <CanonicalSPDI>NC_000022.11:46353796:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="46353797" stop="46353797" display_start="46353797" display_stop="46353797" variantLength="1" positionVCF="46353796" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="46749694" stop="46749694" display_start="46749694" display_stop="46749694" variantLength="1" positionVCF="46749693" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A128fs</ProteinChange>
      <ProteinChange>A154fs</ProteinChange>
      <ProteinChange>A268fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.46749694del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.46749694del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.46353797del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.46353797del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012173.1" sequenceAccession="NG_012173" sequenceVersion="1" change="g.23397del">
            <Expression>NG_012173.1:g.23397del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282782.2" sequenceAccession="NM_001282782" sequenceVersion="2" change="c.461del">
            <Expression>NM_001282782.2:c.461del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269711.1" sequenceAccession="NP_001269711" sequenceVersion="1" change="p.Ala154fs">
            <Expression>NP_001269711.1:p.Ala154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282783.2" sequenceAccession="NM_001282783" sequenceVersion="2" change="c.383del">
            <Expression>NM_001282783.2:c.383del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269712.1" sequenceAccession="NP_001269712" sequenceVersion="1" change="p.Ala128fs">
            <Expression>NP_001269712.1:p.Ala128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282784.2" sequenceAccession="NM_001282784" sequenceVersion="2" change="c.383del">
            <Expression>NM_001282784.2:c.383del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269713.1" sequenceAccession="NP_001269713" sequenceVersion="1" change="p.Ala128fs">
            <Expression>NP_001269713.1:p.Ala128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282785.2" sequenceAccession="NM_001282785" sequenceVersion="2" change="c.803del">
            <Expression>NM_001282785.2:c.803del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269714.1" sequenceAccession="NP_001269714" sequenceVersion="1" change="p.Ala268fs">
            <Expression>NP_001269714.1:p.Ala268fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018006.5" sequenceAccession="NM_018006" sequenceVersion="5" change="c.803del" MANESelect="true">
            <Expression>NM_018006.5:c.803del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060476.2" sequenceAccession="NP_060476" sequenceVersion="2" change="p.Ala268fs">
            <Expression>NP_060476.2:p.Ala268fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_104240.2" sequenceAccession="NR_104240" sequenceVersion="2" change="n.799del">
            <Expression>NR_104240.2:n.799del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_104241.2" sequenceAccession="NR_104241" sequenceVersion="2" change="n.692del">
            <Expression>NR_104241.2:n.692del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="745338284" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018006.5(TRMU):c.803del (p.Ala268fs) AND not provided" Accession="RCV001384177" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018006.5(TRMU):c.803del (p.Ala268fs) AND multiple conditions" Accession="RCV002499800" Version="1">
        <ClassifiedConditionList TraitSetID="10506">
          <ClassifiedCondition DB="MedGen" ID="C3278664">Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1838854">Aminoglycoside-induced deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018006.5(TRMU):c.803del (p.Ala268fs) AND Aminoglycoside-induced deafness" Accession="RCV003473951" Version="2">
        <ClassifiedConditionList TraitSetID="13004">
          <ClassifiedCondition DB="MedGen" ID="C1838854">Aminoglycoside-induced deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-30" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-30" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19732863</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23625533</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13004" Type="DrugResponse" ContributesToAggregateClassification="true">
            <Trait ID="931" Type="DrugResponse">
              <Name>
                <ElementValue Type="Preferred">Aminoglycoside-induced deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEAFNESS, STREPTOMYCIN-INDUCED</ElementValue>
                <XRef Type="MIM" ID="580000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">STREPTOMYCIN OTOTOXICITY</ElementValue>
                <XRef Type="MIM" ID="580000" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Mitochondrial nonsyndromic hearing loss and deafness is characterized by sensorineural hearing loss (SNHL) of variable onset and severity. Pathogenic variants in MT-RNR1 can be associated with predisposition to aminoglycoside ototoxicity and/or late-onset SNHL. Hearing loss associated with aminoglycoside ototoxicity is bilateral and severe to profound, occurring within a few days to weeks after administration of any amount (even a single dose) of an aminoglycoside antibiotic such as gentamycin, tobramycin, amikacin, kanamycin, or streptomycin. Pathogenic variants in MT-TS1 are usually associated with childhood onset of SNHL that is generally nonsyndromic – although the MT-TS1 substitution m.7445A&gt;G has been found in some families who also have palmoplantar keratoderma (scaling, hyperkeratosis, and honeycomb appearance of the skin of the palms, soles, and heels).</Attribute>
                <XRef ID="NBK1422" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18161" />
                <XRef ID="18161" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301595</ID>
                <ID Source="BookShelf">NBK1422</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301607</ID>
                <ID Source="BookShelf">NBK1434</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2012">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a73a5453-c091-43fd-aae2-d992152363b1</URL>
                <CitationText>DailyMed Drug Label, GENTAMICIN, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2013">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abd1f64e-4283-4370-aae8-3666316aa36e</URL>
                <CitationText>DailyMed Drug Label, STREPTOMYCIN, 2013</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2013">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6aab2c4c-148a-4fce-af07-41cd086d9e9c</URL>
                <CitationText>DailyMed Drug Label, TOBRAMYCIN, 2013</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2013">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ec3129b-c53b-4bdb-913d-a2d0060fa140</URL>
                <CitationText>DailyMed Drug Label, AMIKACIN, 2013</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2012">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4865638-1259-4eef-a73c-fe919af6e850</URL>
                <CitationText>DailyMed Drug Label, KANAMYCIN, 2012</CitationText>
              </Citation>
              <Citation Type="review" Abbrev="Medical Genetics Summaries">
                <ID Source="BookShelf">NBK285956</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2021">
                <ID Source="PubMed">34032273</ID>
              </Citation>
              <XRef ID="168609" DB="Orphanet" />
              <XRef ID="C1838854" DB="MedGen" />
              <XRef ID="MONDO:0010799" DB="MONDO" />
              <XRef Type="MIM" ID="580000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10506" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6925" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LIVER FAILURE, INFANTILE, TRANSIENT</ElementValue>
                <XRef Type="MIM" ID="613070" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610230.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610230.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610230.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610230.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610230.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610230.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Liver failure acute infantile</ElementValue>
                <XRef ID="Liver+failure+acute+infantile/4281" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins</ElementValue>
                <XRef ID="MONDO:0013111" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LFIT</ElementValue>
                <XRef Type="MIM" ID="613070" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10593" />
                <XRef ID="10593" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37184193</ID>
                <ID Source="BookShelf">NBK591557</ID>
              </Citation>
              <XRef ID="217371" DB="Orphanet" />
              <XRef ID="C3278664" DB="MedGen" />
              <XRef ID="MONDO:0013111" DB="MONDO" />
              <XRef Type="MIM" ID="613070" DB="OMIM" />
            </Trait>
            <Trait ID="931" Type="DrugResponse">
              <Name>
                <ElementValue Type="Preferred">Aminoglycoside-induced deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEAFNESS, STREPTOMYCIN-INDUCED</ElementValue>
                <XRef Type="MIM" ID="580000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">STREPTOMYCIN OTOTOXICITY</ElementValue>
                <XRef Type="MIM" ID="580000" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Mitochondrial nonsyndromic hearing loss and deafness is characterized by sensorineural hearing loss (SNHL) of variable onset and severity. Pathogenic variants in MT-RNR1 can be associated with predisposition to aminoglycoside ototoxicity and/or late-onset SNHL. Hearing loss associated with aminoglycoside ototoxicity is bilateral and severe to profound, occurring within a few days to weeks after administration of any amount (even a single dose) of an aminoglycoside antibiotic such as gentamycin, tobramycin, amikacin, kanamycin, or streptomycin. Pathogenic variants in MT-TS1 are usually associated with childhood onset of SNHL that is generally nonsyndromic – although the MT-TS1 substitution m.7445A&gt;G has been found in some families who also have palmoplantar keratoderma (scaling, hyperkeratosis, and honeycomb appearance of the skin of the palms, soles, and heels).</Attribute>
                <XRef ID="NBK1422" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18161" />
                <XRef ID="18161" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301595</ID>
                <ID Source="BookShelf">NBK1422</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301607</ID>
                <ID Source="BookShelf">NBK1434</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2012">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a73a5453-c091-43fd-aae2-d992152363b1</URL>
                <CitationText>DailyMed Drug Label, GENTAMICIN, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2013">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abd1f64e-4283-4370-aae8-3666316aa36e</URL>
                <CitationText>DailyMed Drug Label, STREPTOMYCIN, 2013</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2013">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6aab2c4c-148a-4fce-af07-41cd086d9e9c</URL>
                <CitationText>DailyMed Drug Label, TOBRAMYCIN, 2013</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2013">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ec3129b-c53b-4bdb-913d-a2d0060fa140</URL>
                <CitationText>DailyMed Drug Label, AMIKACIN, 2013</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2012">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4865638-1259-4eef-a73c-fe919af6e850</URL>
                <CitationText>DailyMed Drug Label, KANAMYCIN, 2012</CitationText>
              </Citation>
              <Citation Type="review" Abbrev="Medical Genetics Summaries">
                <ID Source="BookShelf">NBK285956</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2021">
                <ID Source="PubMed">34032273</ID>
              </Citation>
              <XRef ID="168609" DB="Orphanet" />
              <XRef ID="C1838854" DB="MedGen" />
              <XRef ID="MONDO:0010799" DB="MONDO" />
              <XRef Type="MIM" ID="580000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5461753" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_018006.5:c.803del|OMIM:580000;580000;613070" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002811612" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018006.5:c.803del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="DrugResponse">
            <XRef DB="OMIM" ID="580000" Type="MIM" />
          </Trait>
          <Trait Type="DrugResponse">
            <XRef DB="OMIM" ID="580000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613070" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3109204" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11674518|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583564" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19732863</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23625533</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals affected with TRMU-related conditions. This variant is present in population databases (rs745338284, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Ala268Glufs*3) in the TRMU gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRMU are known to be pathogenic (PMID: 19732863, 23625533). ClinVar contains an entry for this variant (Variation ID: 1071658). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRMU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.46749694del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7850945" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_018006.5:c.803del|OMIM:580000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004204354" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018006.5:c.803del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="DrugResponse">
          <Trait Type="DrugResponse">
            <XRef DB="OMIM" ID="580000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3109204" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5461753" TraitType="DrugResponse" MappingType="XRef" MappingValue="580000" MappingRef="OMIM">
        <MedGen CUI="C1838854" Name="Aminoglycoside-induced deafness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5461753" TraitType="Disease" MappingType="XRef" MappingValue="613070" MappingRef="OMIM">
        <MedGen CUI="C3278664" Name="Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7850945" TraitType="DrugResponse" MappingType="XRef" MappingValue="580000" MappingRef="OMIM">
        <MedGen CUI="C1838854" Name="Aminoglycoside-induced deafness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5461753" TraitType="DrugResponse" MappingType="XRef" MappingValue="580000" MappingRef="OMIM">
        <MedGen CUI="C1838854" Name="Aminoglycoside-induced deafness" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

